TACCONELLI, Evelina
 Distribuzione geografica
Continente #
EU - Europa 11.729
NA - Nord America 11.435
AS - Asia 9.103
SA - Sud America 1.664
AF - Africa 442
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 34.430
Nazione #
US - Stati Uniti d'America 11.101
RU - Federazione Russa 4.985
SG - Singapore 3.888
IT - Italia 2.109
CN - Cina 1.965
GB - Regno Unito 1.535
BR - Brasile 1.320
VN - Vietnam 927
HK - Hong Kong 901
DE - Germania 618
FR - Francia 601
IE - Irlanda 516
SE - Svezia 423
KR - Corea 293
BD - Bangladesh 259
FI - Finlandia 257
IN - India 180
CA - Canada 172
JP - Giappone 134
NL - Olanda 131
AR - Argentina 124
NG - Nigeria 115
TR - Turchia 109
MX - Messico 98
AT - Austria 91
ES - Italia 81
ZA - Sudafrica 75
ID - Indonesia 70
TG - Togo 69
UA - Ucraina 65
PL - Polonia 63
EC - Ecuador 59
BJ - Benin 56
IQ - Iraq 54
CO - Colombia 44
PK - Pakistan 43
CZ - Repubblica Ceca 38
AU - Australia 35
BE - Belgio 33
LT - Lituania 33
PH - Filippine 30
UZ - Uzbekistan 30
SA - Arabia Saudita 28
CL - Cile 27
GR - Grecia 27
VE - Venezuela 27
EG - Egitto 25
MA - Marocco 25
MY - Malesia 23
PE - Perù 21
AE - Emirati Arabi Uniti 19
RO - Romania 19
JO - Giordania 18
AZ - Azerbaigian 17
UY - Uruguay 17
PT - Portogallo 16
TW - Taiwan 15
DZ - Algeria 14
KE - Kenya 14
CH - Svizzera 13
NP - Nepal 13
TN - Tunisia 13
KZ - Kazakistan 12
PY - Paraguay 12
SI - Slovenia 11
CR - Costa Rica 10
EU - Europa 10
HU - Ungheria 10
BO - Bolivia 9
IL - Israele 9
RS - Serbia 9
AL - Albania 8
IR - Iran 8
LB - Libano 8
OM - Oman 8
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
HR - Croazia 6
JM - Giamaica 6
NI - Nicaragua 6
PA - Panama 6
SN - Senegal 6
ET - Etiopia 5
GT - Guatemala 5
NZ - Nuova Zelanda 5
AM - Armenia 4
AO - Angola 4
BG - Bulgaria 4
BH - Bahrain 4
DK - Danimarca 4
GH - Ghana 4
HN - Honduras 4
LV - Lettonia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
DM - Dominica 3
Totale 34.364
Città #
Singapore 2.026
Moscow 1.699
Ashburn 1.648
Dallas 1.643
San Jose 1.363
Southend 1.176
Verona 1.074
Chandler 949
Hong Kong 884
The Dalles 504
Dublin 495
Beijing 386
New York 318
Council Bluffs 316
Ho Chi Minh City 309
Los Angeles 257
Redmond 224
Hanoi 216
Lawrence 174
Princeton 174
Jacksonville 156
Munich 153
Buffalo 136
São Paulo 127
Wilmington 125
Tokyo 120
Helsinki 114
Abuja 111
London 107
Redondo Beach 106
Santa Clara 104
Jinan 100
Nanjing 82
Sindelfingen 80
Orem 76
Milan 75
Shenyang 75
Frankfurt am Main 74
Columbus 70
Lappeenranta 69
Lomé 69
Seattle 67
Boardman 65
Nuremberg 65
Montreal 64
Tianjin 62
Turku 59
Amsterdam 58
Chennai 58
Cotonou 56
Bologna 55
Chicago 55
Atlanta 53
Vienna 53
Warsaw 52
Ann Arbor 50
Brooklyn 49
Houston 49
Toronto 49
Denver 45
Haikou 44
Johannesburg 43
Boydton 42
Rome 42
Zhengzhou 42
Haiphong 40
Hebei 39
Guangzhou 38
Ningbo 38
Da Nang 37
Nanchang 37
Changsha 36
Phoenix 36
Rio de Janeiro 36
San Francisco 36
Manchester 35
Mexico City 35
Washington 33
Brussels 32
Belo Horizonte 30
Hangzhou 30
Stockholm 30
Dong Ket 29
Tashkent 29
Jiaxing 27
Seoul 27
Ankara 26
Madrid 26
Brno 25
Poplar 25
Boston 24
City of London 24
Taizhou 24
Curitiba 22
Jakarta 22
Lahore 22
Taiyuan 22
Woodbridge 22
Dhaka 21
Fortaleza 21
Totale 20.277
Nome #
Lessons from the European Mpox Outbreak: Strengthening Cohort Research for Future Pandemic Preparedness 448
Risk Factors for Persisting SARS-CoV-2 Infection in Patients with B-Cell Malignancies in the Omicron Era: A Multicenter Cohort Study 308
Active surveillance for early detection of SARS-CoV-2 infections across high-risk community key populations. 266
Deciphering the state of immune silence in fatal COVID-19 patients 240
A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine 217
Assessment of COVID-19 progression on day 5 from symptoms onset 215
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project 204
How to ‘SAVE’ antibiotics: effectiveness and sustainability of a new model of antibiotic stewardship intervention in the internal medicine area 201
European Society of Clinical Microbiology and Infectious Diseases/European Committee on infection control clinical guidelines on pre-operative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery 200
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 199
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 198
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe 196
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 196
Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors? 193
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis 193
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli 192
A Digital Approach to Improve Infection Screening Among Solid Organ Transplant Candidates 191
Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica 191
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 191
Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? 190
Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis 189
Frequency of bloodstream infections caused by six key antibiotic-resistant pathogens for prioritization of research and discovery of new therapies in Europe: a systematic review 188
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage 187
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 187
Nervous system: subclinical target of SARS-CoV-2 infection 186
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 186
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 182
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis 181
Clinical management of severe infections caused by carbapenem-resistant Gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations 181
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 179
[Infectious diseases as a clinical specialty in Germany and Europe] 177
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population 176
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group 176
Metallo-b-lactamases as emerging resistance determinants in gram-negative pathogens: open issues 175
Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list 175
European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine) 174
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia 173
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 172
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study 171
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 170
A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements 169
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 169
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues 167
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 166
Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae 165
[Antibiotic Stewardship 2.0. Individualization of therapy] 164
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency 164
Management of obstetrics and gynaecological patients with COVID-19 164
High rate of pulmonary thromboembolism in patients with SARS-CoV-2 pneumonia 163
Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol 162
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 161
Public health burden of antimicrobial resistance in Europe 159
A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies 159
[Erratum to: Antibiotic Stewardship 2.0 : Individualization of therapy] 158
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 157
A one health framework to estimate the cost of antimicrobial resistance 156
A framework to develop semiautomated surveillance of surgical site infections: An international multicenter study 156
A survey of methicillin-resistant Staphylococcus aureus control strategies in Italy 156
An Antibiotic Stewardship Program in Pancreatic Surgery 156
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times 155
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern 154
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case 154
Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries 154
Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions 153
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 153
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 153
The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread 152
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response 151
White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector-practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks 150
Community case study for surveillance and early case-detection of SARS-CoV-2 infections across high-risk key populations: the Sentinella programme 150
Detection of SARS-CoV-2 Δ426 ORF8 Deletion Mutant Cluster in NGS Screening 149
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance system target bacteria 149
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 147
Author Correction: Modelling antimicrobial resistance transmission to guide personalized antimicrobial stewardship interventions and infection control policies in healthcare setting: a pilot study 147
The Impact of Antibiotic Prophylaxis on Antibiotic Resistance, Clinical Outcomes, and Costs in Adult Hemato-Oncological and Surgical Patients: A Systematic Review and Meta-Analysis 147
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae 146
Outbreak of Saprochaete clavata Sepsis in Hematology Patients: Combined Use of MALDI-TOF and Sequencing Strategy to Identify and Correlate the Episodes 146
The gut microbiota as an early predictor of COVID-19 severity 145
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 145
Diagnostic accuracy of point-of-care tests in acute community acquired-lower respiratory tract infections. A systematic review and meta-analysis 145
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries 144
ESCMID-EUCIC clinical guidelines on decolonisation of multidrug-resistant Gram-negative bacteria carriers 143
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment 143
Role of new antibiotics for KPC-producing Klebsiella pneumoniae 142
Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study 142
Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study 142
Aggressive versus conservative initiation of antibiotics 141
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 141
Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting 140
Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone 138
Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodies 138
Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list-authors' response 137
Exploring Viral Genome Profile in Mpox Patients during the 2022 Outbreak, in a North-Eastern Centre of Italy 136
EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach 135
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 135
Dalbavancin in the treatment of acute bacterial skin and skin structure and other infections: a safety evaluation 134
Antibiotic research and development: business as usual? 134
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region 133
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance 132
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients 132
Totale 16.992
Categoria #
all - tutte 127.354
article - articoli 126.173
book - libri 0
conference - conferenze 1.006
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 175
Totale 254.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 0 0 78
2021/20221.515 161 303 44 39 39 47 26 137 148 53 113 405
2022/20233.196 200 363 299 576 218 769 40 216 333 30 90 62
2023/20242.201 97 142 155 222 292 368 155 199 14 123 278 156
2024/20256.109 335 298 227 956 290 206 446 295 997 466 513 1.080
2025/202619.132 1.231 1.330 1.460 3.082 4.421 1.070 1.754 1.178 1.544 1.110 493 459
Totale 35.167